Assessing the biocompatibility and stability of CeO₂ nanoparticle conjugates with azacrowns for use as radiopharmaceuticals

Abstract

stability of the studied scandium complex was demonstrated. Taken together, our studies show that functionalised cerium oxide nanoparticles lead to stable radiolabelled nanosystems that may be used for targeted drug delivery, diagnosis and treatment of oncological diseases.